| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1586/14787210.5.5.833 |
| P698 | PubMed publication ID | 17914917 |
| P2093 | author name string | John P Quinn | |
| Maria Virginia Villegas | |||
| Julián Andrés Torres | |||
| P2860 | cites work | Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 |
| Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics | Q48611808 | ||
| Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-1, a novel transferable metallo-beta-lactamase. | Q54030470 | ||
| Quinolone resistance from a transferable plasmid. | Q54143628 | ||
| Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. | Q54302049 | ||
| Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections. | Q54424813 | ||
| Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). | Q54562042 | ||
| Extended-spectrum beta-lactamases: a clinical update | Q24534999 | ||
| Plasmid-determined AmpC-type beta-lactamases | Q24535748 | ||
| Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae | Q24550605 | ||
| Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa | Q28256421 | ||
| Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa | Q28492521 | ||
| Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa | Q28492598 | ||
| The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan | Q28492850 | ||
| Molecular basis of bacterial outer membrane permeability | Q29617897 | ||
| National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. | Q30977541 | ||
| Resistance patterns among nosocomial pathogens: trends over the past few years | Q31920743 | ||
| Identification of an OprD homologue in Acinetobacter baumannii | Q33228855 | ||
| Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe | Q33556074 | ||
| Metallo-beta-lactamases: the quiet before the storm? | Q33755227 | ||
| Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV | Q33883611 | ||
| Broader distribution of plasmid-mediated quinolone resistance in the United States | Q33883639 | ||
| First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-beta-lactamase (VIM-2) in the United States | Q33938126 | ||
| The new beta-lactamases. | Q33984601 | ||
| Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia | Q34042432 | ||
| Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii | Q34077024 | ||
| Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. | Q34177418 | ||
| The threat from the pink corner | Q34212044 | ||
| Channel formation by CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii | Q34228361 | ||
| Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents | Q34352265 | ||
| Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center | Q34370760 | ||
| 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides | Q34635355 | ||
| Acquired carbapenem-hydrolyzing beta-lactamases and their genetic support | Q34647842 | ||
| Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria | Q34647905 | ||
| Emerging carbapenemases in Gram-negative aerobes | Q34707048 | ||
| Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. | Q34884093 | ||
| qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States | Q34973794 | ||
| Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain | Q34990153 | ||
| Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme | Q35127937 | ||
| Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil | Q35155708 | ||
| The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists | Q35186545 | ||
| Properties and potential of ertapenem | Q35199054 | ||
| The aminoglycoside 6'-N-acetyltransferase type Ib encoded by Tn1331 is evenly distributed within the cell's cytoplasm | Q35685247 | ||
| Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp. | Q35690304 | ||
| Resistance to beta-lactam antibiotics | Q35874928 | ||
| New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate | Q36094929 | ||
| The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter | Q36550851 | ||
| Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology | Q36553871 | ||
| Doripenem versus Pseudomonas aeruginosa in vitro: activity against characterized isolates, mutants, and transconjugants and resistance selection potential | Q36670323 | ||
| CTX-M: changing the face of ESBLs in Europe | Q36678524 | ||
| Modes and modulations of antibiotic resistance gene expression | Q36708242 | ||
| Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. | Q36746061 | ||
| Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States | Q37121208 | ||
| Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system | Q37489413 | ||
| Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France | Q39473408 | ||
| Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa | Q39475663 | ||
| SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia | Q39651167 | ||
| Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates | Q39730764 | ||
| Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia | Q40282230 | ||
| Trends in antimicrobial drug development: implications for the future | Q40512558 | ||
| Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii | Q40667900 | ||
| Prevalence and genetic analysis of plasmid-mediated quinolone resistance determinants QnrA and QnrS in Enterobacteriaceae isolates from a French university hospital | Q40903405 | ||
| Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York | Q41003539 | ||
| Plasmid-mediated quinolone resistance in isolates obtained in german intensive care units | Q41005560 | ||
| Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals | Q41789812 | ||
| Involvement of the MexXY-OprM efflux system in emergence of cefepime resistance in clinical strains of Pseudomonas aeruginosa | Q41827007 | ||
| First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase | Q42112242 | ||
| Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. | Q42112359 | ||
| First detection of metallo-beta-lactamase VIM-2 in Pseudomonas aeruginosa isolates from Colombia | Q42112530 | ||
| High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. | Q42165253 | ||
| First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy | Q42408826 | ||
| Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France | Q42564925 | ||
| Molecular and structural characterization of the HMP-AB gene encoding a pore-forming protein from a clinical isolate of Acinetobacter baumannii | Q42615334 | ||
| Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii | Q42747669 | ||
| Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? | Q43874264 | ||
| Metallo-beta-lactamase-producing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii | Q44160978 | ||
| Long-term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula | Q44229881 | ||
| Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates | Q44342622 | ||
| Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations | Q44931240 | ||
| Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital | Q45068044 | ||
| A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58. | Q45182367 | ||
| Escherichia coli: development of carbapenem resistance during therapy | Q46448530 | ||
| Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001). | Q46641592 | ||
| First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital | Q46801077 | ||
| Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003). | Q46819792 | ||
| P433 | issue | 5 | |
| P921 | main subject | Gram-negative bacteria | Q632006 |
| P304 | page(s) | 833-843 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Expert Review of Anti-infective Therapy | Q15734432 |
| P1476 | title | Current concepts in antibiotic-resistant gram-negative bacteria | |
| P478 | volume | 5 |
| Q34156349 | Antibiotics and bacterial resistance in the 21st century |
| Q24634999 | Carbapenems: past, present, and future |
| Q64092542 | Complement-dependent outer membrane perturbation sensitizes Gram-negative bacteria to Gram-positive specific antibiotics |
| Q53295716 | Discovery of the highly potent fluoroquinolone-based benzothiazolyl-4-thiazolidinone hybrids as antibacterials. |
| Q37228745 | Economics of antibiotic resistance |
| Q89485251 | Prevalence and characterization of carbapenem-resistant bacteria in water bodies in the Los Angeles-Southern California area |
| Q54400707 | Protection of Salmonella by ampicillin-resistant Escherichia coli in the presence of otherwise lethal drug concentrations. |
| Q41420121 | Sensitization of Gram-negative bacteria to rifampin and OAK combinations |
| Q21245787 | Studies on the antimicrobial activity and brine shrimp toxicity of Zeyheria tuberculosa (Vell.) Bur. (Bignoniaceae) extracts and their main constituents |
| Q34770892 | The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants |
Search more.